NCT06017973View on ClinicalTrials.gov

The Role of Imaging in the Diagnosis, Management and Prognosis of Possible Non-convulsive Status Epilepticus

NARecruitingINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

October 1, 2023

Primary Completion Date

September 30, 2027

Study Completion Date

September 30, 2027

Conditions
Status EpilepticusIctal-interictal ContinuumPositron-emission TomographyPerfusion Weighted MRIPerfusion CT
Interventions
DIAGNOSTIC_TEST

MRI scan including arterial spin labelling of the brain

Arterial Spin Labelling sequence, T2-weighted FLAIR images and T1-weighted images and diffusion weighted imaging sequence will be recorded

DIAGNOSTIC_TEST

CT perfusion scan of the brain

Siemens Naeotom Alpha with quantum technology (photon-counting)

DIAGNOSTIC_TEST

FDG-PET scan of the brain

An FDG-PET scan will be acquired on a GE Signa 3T PET-MR scanner. FDG-PET images will be assessed for focal hypermetabolism, including semiquantitative analysis of the maximal standard uptake value (SUVmax) relative to the SUVmax of the pons (SUVr pons)

Trial Locations (1)

3000

RECRUITING

University Hospitals Leuven, department of Neurology, Leuven

All Listed Sponsors
lead

Universitaire Ziekenhuizen KU Leuven

OTHER